论文部分内容阅读
卵巢是恶性肿瘤较为常见的转移部位,常见于原发性结直肠癌、阑尾癌、乳腺癌。有学者统计,乳腺癌的卵巢转移率约40%,可见其发生率并不低,但临床上典型病例却并不多见。目前研究表明,乳腺癌卵巢转移多发于绝经前激素受体阳性患者,常为双侧转移,病理学多表现为浸润性小叶癌。作者通过分析1例化疗后绝经女性乳腺浸润性导管癌单侧卵巢转移的少见病例,复习相关文献,探讨国内外相关研究现状,提出在普外科接诊乳腺癌时,术前应关注年龄、家族史等,术后重视病理分型及相关蛋白的免疫组化结果,形成规范化妇科复查再评估体系的理论。
Ovarian cancer is a more common metastatic site, common in primary colorectal cancer, appendix cancer, breast cancer. Some scholars statistics, breast cancer ovarian metastasis rate of about 40%, we can see the incidence is not low, but the typical cases are clinically rare. The current study shows that breast cancer ovarian metastasis in premenopausal hormone receptor-positive patients, often bilateral metastasis, pathology and more manifestations of invasive lobular carcinoma. By analyzing the rare cases of unilateral ovarian metastasis of invasive ductal carcinoma of breast in postmenopausal women after chemotherapy, the author reviews the relevant literature and discusses the current status of relevant research at home and abroad. It is suggested that preoperative diagnosis of breast cancer should focus on the age, family History, postoperative emphasis on pathological classification and immunohistochemical results of related proteins, the formation of standardized gynecological review re-evaluation system theory.